BioNeutra International, Ltd.
BIMO · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Market Cap | $833 | $261 | $9,806 | $6,537 |
| - Cash | $0 | $0 | $11 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $833 | $261 | $9,795 | $6,537 |
| Revenue | $0 | $0 | $33 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $26 | -$7 |
| % Margin | – | – | 79.3% | – |
| EBITDA | -$54 | -$55 | -$52 | -$2 |
| % Margin | – | – | -156.8% | – |
| Net Income | -$68 | -$55 | -$59 | -$8 |
| % Margin | – | – | -177.4% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | -33.3% | 25% | -300% | – |
| Operating Cash Flow | -$0 | – | $11 | -$0 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | -$0 | – | $11 | -$0 |